208 related articles for article (PubMed ID: 9222053)
21. Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages.
Walz A; Nichterlein T; Hof H
Zentralbl Bakteriol; 1997 Feb; 285(3):431-9. PubMed ID: 9084116
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
Edelstein PH; Gaudet EA; Edelstein MA
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic susceptibility of environmental
Sreenath K; Chaudhry R; Vinayaraj EV; Thakur B
Future Microbiol; 2019 May; 14():661-669. PubMed ID: 31148475
[No Abstract] [Full Text] [Related]
24. In-vitro activity of antibiotics against Legionella pneumophila isolates from water systems.
Tsakris A; Alexiou-Daniel S; Souliou E; Antoniadis A
J Antimicrob Chemother; 1999 Nov; 44(5):693-5. PubMed ID: 10552988
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic Resistance of
Pappa O; Chochlakis D; Sandalakis V; Dioli C; Psaroulaki A; Mavridou A
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32796666
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the activity of antimicrobial agents against Legionella pneumophila multiplying in a human monocytic cell line, THP-1, and an alveolar epithelial cell line, A549.
Kunishima H; Takemura H; Yamamoto H; Kanemitsu K; Shimada J
J Infect Chemother; 2000 Dec; 6(4):206-10. PubMed ID: 11810567
[TBL] [Abstract][Full Text] [Related]
28. In-vitro activity of six intracellular antibiotics against Legionella pneumophila strains of human and environmental origin.
Reda C; Quaresima T; Pastoris MC
J Antimicrob Chemother; 1994 Apr; 33(4):757-64. PubMed ID: 8056694
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of ninety-eight clinical isolates of Legionella to macrolides and quinolones using the Etest.
Schrock J; Hackman BA; Plouffe JF
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):221-3. PubMed ID: 9327252
[TBL] [Abstract][Full Text] [Related]
30. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Dubois J; Joly JR
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of macrolides against intracellular Legionella pneumophila.
Segreti J; Meyer P; Kapell K
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
[TBL] [Abstract][Full Text] [Related]
32. Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila.
Reznicek M; Bale M; Pfaller M
Diagn Microbiol Infect Dis; 1991; 14(1):7-10. PubMed ID: 2013212
[TBL] [Abstract][Full Text] [Related]
33. Isolation of ciprofloxacin-resistant Legionella pneumophila in a patient with severe pneumonia.
Bruin JP; Koshkolda T; IJzerman EP; Lück C; Diederen BM; Den Boer JW; Mouton JW
J Antimicrob Chemother; 2014 Oct; 69(10):2869-71. PubMed ID: 24898020
[No Abstract] [Full Text] [Related]
34. In vitro activity of thiamphenicol, erythromycin and fluoroquinolones against Legionella pneumophila.
Bonfiglio G; Lanzafame A; Santini L; Mattina R
J Chemother; 2004 Oct; 16(5):502-3. PubMed ID: 15565921
[No Abstract] [Full Text] [Related]
35. Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation.
Marco F; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1997 Sep; 29(1):55-7. PubMed ID: 9350417
[TBL] [Abstract][Full Text] [Related]
36. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA; Lehr KH; Ren J
J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
[TBL] [Abstract][Full Text] [Related]
37. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.
Bruin JP; Ijzerman EP; den Boer JW; Mouton JW; Diederen BM
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):103-8. PubMed ID: 22100012
[TBL] [Abstract][Full Text] [Related]
38. The Etest for antimicrobial susceptibility testing of Bartonella henselae.
Wolfson C; Branley J; Gottlieb T
J Antimicrob Chemother; 1996 Dec; 38(6):963-8. PubMed ID: 9023643
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of Legionella species to antimicrobial agents.
Chen SC; Paul ML; Gilbert GL
Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A
J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
